Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSTL | GYRE | BBOT | ||
| Company | Castle Biosciences Inc | Gyre Therapeutics Inc | Bridgebio Oncology Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 25.14 | 8.00 | 9.36 | ||
| High | 25.36 | 8.20 | 9.65 | ||
| Low | 24.83 | 7.97 | 9.23 | ||
| Latest | 25.05 | 8.10 | 9.35 | ||
| Change | +0.49 | +0.20 | +0.13 | ||
| % Change | +2.00% | +2.53% | +1.41% | ||
| Volume | 214,800 | 89,900 | 586,300 | ||
| 20-Day Average Volume | 290,300 | 89,270 | 319,310 | ||
| Previous Close | 24.56 | 7.90 | 9.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 24.55 | 7.27 | 8.92 | ||
| 20-Day Raw Stochastic | 66.67% | 93.83% | 80.98% | ||
| 20-Day Relative Strength | 42.45 | 57.68 | 48.87 | ||
| Weighted Alpha | -5.40 | -0.97 | -20.71 | ||
| Today's Opinion | 72% Sell | 40% Buy | 88% Sell | ||
| Previous Opinion | 88% Sell | 24% Buy | 88% Sell | ||
| Last Month's Opinion | 40% Sell | 8% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.30% since 04/10/26 | +9.61% since 04/10/26 | +11.31% since 04/10/26 | ||
| Low | 22.81 on 04/13/26 | 7.31 on 04/13/26 | 8.50 on 04/14/26 | ||
| High | 25.36 on 04/17/26 | 8.20 on 04/17/26 | 9.65 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -3.28% since 03/17/26 | +5.88% since 03/17/26 | -1.37% since 03/17/26 | ||
| Low | 21.79 on 04/10/26 | 6.58 on 03/20/26 | 8.08 on 04/07/26 | ||
| High | 26.68 on 04/08/26 | 8.20 on 04/17/26 | 9.65 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | -37.39% since 01/16/26 | +5.47% since 01/16/26 | -18.09% since 01/16/26 | ||
| Low | 21.79 on 04/10/26 | 6.58 on 03/20/26 | 8.08 on 04/07/26 | ||
| High | 44.28 on 01/26/26 | 9.14 on 03/05/26 | 13.99 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +13.14% since 10/17/25 | -2.41% since 10/17/25 | -16.14% since 10/17/25 | ||
| Low | 21.79 on 04/10/26 | 6.58 on 03/20/26 | 8.08 on 04/07/26 | ||
| High | 44.28 on 01/26/26 | 9.14 on 03/05/26 | 14.87 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 758,915 | 785,408 | 748,309 | ||
| Shares Outstanding, K | 30,296 | 96,964 | 80,033 | ||
| Annual Sales | 344,230,000 | 116,590,000 | 0 | ||
| Annual Net Income | -24,160,000 | 5,030,000 | -134,040,000 | ||
| Last Quarter Sales | 87,010,000 | 37,200,000 | 0 | ||
| Last Quarter Net Income | -2,330,000 | -1,720,000 | -38,800,000 | ||
| 60-Month Beta | 1.18 | 2.10 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 02/26/26 | 0.04 on 03/12/26 | -0.49 on 03/05/26 | ||
| Latest Earnings Date | 05/06/26 | 05/08/26 | 06/04/26 | ||
| Most Recent Dividend | N/A | 0.569 on 08/20/15 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 71.82 | 0.00 | ||